IP Library Assignment 031485/0800
Patent Assignment
Reel/Frame 031485/0800

Change of Name

Recorded: 2013-10-24 Pages: 2
Assignor
CEPHALON AUSTRALIA PTY LTD
Executed: 2013-08-30
Assignee
TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
RON KAL, LOCKED BAG 2053, NORTH RYDE, NSW, 1670, AUSTRALIA
Covered Property (1)
Binding Member Which Binds to Both Lewis-Y and Lewis-B Haptens, and Its Use for Treating Cancer
Patent: 7,879,983 →
Application: 12/505,313 →
Publication: US 2009/0281285
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 22, 2009
From: DURRANT, LINDA G.; PARSONS, TINA
To: SCANCELL LIMITED
Reel/Frame 022988/0752 →
Assignment of Assignor's Interest Jul 22, 2009
From: SCANCELL LIMITED
To: ARANA THERAPEUTICS LIMITED
Reel/Frame 022988/0786 →
Change of Name Sep 1, 2010
From: ARANA THERAPEUTICS LIMITED
To: ARANA THERAPEUTICS PTY LTD
Reel/Frame 024922/0982 →
Change of Name Sep 2, 2010
From: ARANA THERAPEUTICS PTY LTD
To: CEPHALON AUSTRALIA PTY LTD
Reel/Frame 024929/0966 →
Corrective Assignment to Correct the Correction of the Assignee Address to Remove "Ron Kal" from the Address Previously Recorded on Reel 031485 Frame 0800. Assignor(S) Hereby Confirms the Name Change from Cephalon Australia Ptyltd to Teva Pharmaceuticals Australia Pty. Dec 9, 2013
From: CEPHALON AUSTRALIA PTY LTD
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 032269/0198 →